Imatinib 400mg

DRUG4 trials

Sponsors

Assiut University, Shanghai Zhongshan Hospital, Peking University, Niaz Ahmed

Conditions

Acute Ischaemic StrokeChronic Myeloid LeukemiaGISTMethod of Differentiating Benignancy and Malignancy, Grading and Staging for GIST

Early Phase 1

Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia

Assiut UniversityChronic Myeloid Leukemia

Start: 2017-12-01End: 2020-08-01Target: 100Updated: 2017-10-10

Phase 3

Imatinib in Acute Ischaemic Stroke

Niaz AhmedAcute Ischaemic Stroke

Start: 2018-10-01End: 2023-06-30Target: 1260Updated: 2020-09-16

Unknown Phase

Study to Compare Pathologic Type, NIH and WHO Criteria,and Mechanism of GIST Malignant Transformation

Shanghai Zhongshan HospitalMethod of Differentiating Benignancy and Malignancy, Grading and Staging for GIST

Start: 2017-07-01End: 2022-01-01Target: 3000Updated: 2017-12-21

To Compare the Efficacy of Surgery Followed by Sunitinib With Surgery Followed by Imatinib in GIST Patients With Progression on Imatinib.

Peking UniversityGIST

Start: 2017-06-02End: 2018-08-08Target: 60Updated: 2018-03-01

Related Papers

Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders

Neural Regeneration Research2022-09-213 citations